The cassette is used for the qualitative detection of novel coronavirus IgM and IgG antibodies in human whole blood, serum or plasma.

Malaria (P. f/P. v) Antigen Testing Kit is a rapid self-performing, qualitative, two site sandwich immunoassay, utilizing whole blood for the detection of P.falciparum specific histidine rich protein-2 (P.f HRP-2) and P.vivax specific pLDH. The test may also be used for specific detection and differentiation of P. falciparum and P. vivax malaria in whole blood samples and for the follow up of anti-malarial therapy.

Biomarkers Abbr. Specimen Expected values Expected values Measuring range Inflammation Procalcitonin PCT Serum/Whole Blood ·Indicate sepsis and bacterial infection ＜0.05 ng/mL 0.05-100 ng/mL Full Range C-reactive Protein CRP Plasma/Whole Blood ·Low risk of cardiovascular disease ·Medium risk of cardiovascular disease ·High risk of cardiovascular disease ·Detecting conventional inflammation hs-CRP:＜1.0 mg/L hs-CRP: 1.0-3.0 mg/L hs-CRP:＞3.0 mg/L CRP:≦10 mg/L 0.5-200 mg/L C-reactive Protein/Amyloid proteinase A 2-in-1 CRP/SAA Serum/Plasma/Whole Blood ·Low risk of cardiovascular disease ·Medium risk of cardiovascular disease ·High risk of cardiovascular disease ·Identify the type of infection and guide the use of antibiotics hs-CRP:＜1.0 mg/L hs-CRP:1.0-3.0 mg/L hs-CRP:＞3.0 mg/L CRP:≦10 mg/L, SAA:≦6.4 mg/L CRP: 0.5-200 mg/L SAA: 2-220 mg/L Immune Rheumatism 3-in-1 ASO/RF/CRP Serum/Plasma/Whole Blood ·Indicators of systemic inflammation ·To assist in the diagnosis, classification and prognosis of rheumatoid arthritis ASO:≦200 IU/mL RF:≦20 IU/mL CRP:≦10 mg/L ASO:50-500 IU/mL RF:10-200 IU/mL CRF:0.5-200 mg/L *Anti cyclic citrullinated peptide antibody Anti-CCP Serum/Plasma/Whole Blood ·Assistant diagnostic indexe of rheumatoid arthritis ≦25 U/mL 25-1000 U/mL Cardiovascular Cardiac Troponin I cTnI Serum/Plasma/Whole Blood ·Diagnose AMI, risk stratification and evaluate prognosis ·Value markers of non ST segment elevation MI ≦0.3 ng/mL 0.1-50 ng/mL Creatine Kinase-MB CK-MB Serum/Plasma/Whole Blood ·Negative exclusion of early AMI; Detection of recurrence and thrombolytic therapy ≦5 ng/mL 1-100 ng/mL Myoglobin MYO Serum/Plasma/Whole Blood ·Early diagnosis of AMI ≦70 ng/mL 5-500 ng/mL Myocardial Infarction (MI) 3-in-1 cTnI/MYO/ CK-MB Serum/Plasma/Whole Blood ·Same as above 3 markers cTnI:≦0.3 ng/mL MYO:≦70 ng/mL CK-MB:≦5 ng/mL cTnI: 0.1-50 ng/mL MYO: 5-500 ng/mL CK-MB: 1-100 ng/mL D-Dimer（D-Dimer） D-Dimer Plasma/Whole Blood ·Exclusion and diagnosis of venous thromboembolism ≦0.5 mg/L 0.1-10 mg/L N-terminal B-type natriuretic peptide NT-proBNP Serum/Plasma/Whole Blood ·Diagnosis heart failure, risk stratification and prognostic evaluation ≦300 pg/mL 50-35000 pg/mL *Lipoprotein-Associated Phospholipase A2 Lp-PLA2 Serum/Plasma/Whole Blood ·Indicating the stability of atherosclerotic plaque ·Predicting the risk of coronary heart disease and stroke ≦200ng/mL 20-1000 ng/mL *cTnI/NT-proBNP/D-Dimer 3-in-1 cTnI/ NT-proBNP/ D-Dimer Plasma/Whole Blood ·Same as above 3 markers cTnI:≦0.3 ng/mL NT-proBNP:≦300 pg/mL D-Dimer:≦0.5 mg/L cTnI: 0.1-50 ng/mL NT-proBNP: 100-20000 pg/mL D-Dimer: 0.1-10 mg/L Digestion *Pepsinogen I/ Pepsinogen II & 2-in-1 PGI/PGII Serum/Plasma/Whole Blood ·Screening of high risk population of gastric cancer ·Indexes of various gastric functional diseases PGI＜70 ng/mL and PGR (PGI/PGII ratio)＜3.0 PGI: 5-300 ng/mL PGII: 2-70 ng/mL *Gastrin 17 G17 Serum/Plasma/Whole Blood Reflecting both the structure and funtion of the stomach antrum. 1-7 pmol/L 1-50 pmol/L Anaemia Ferritin FER Serum/Plasma/Whole Blood ·One of the diagnostic indexes of invisible iron deficiency anemia and liver disease ·One of malignant tumor markers Male（age 20-60）：30-400 μg/L Female（age 17-60）：13-150 μg/L 5-1000 μg/L Diabetes & Renal Injury β_2-Microglobulin β2-MG Serum/Urine ·Sensitive indicators of crypto acute and chronic kidney diseases ·Detection indexes of various tumors Urine：0.10-0.30mg/L Serum：1.011-2.97mg/L 0.1-20 mg/L Cystatin C Cys-C Serum ·Detection indexes of early diabetic nephropathy and hypertensive nephropathy 0.57-1.01 mg/L 0.2-10 mg/L Neutrophil Gelatinase-Associated Lipocalin NGAL Urine ·Early diagnosis of acute kidney injury (AKI) ＜131.7 ng/mL 5-1500 ng/mL Urine Microalbumin mAlb Urine ·Reflect the situation of early nephropathy and renal injury ≦20 mg/L 5-300mg/mL C-Peptide C-P Serum ·Classification of diabetes mellitus and judgment of islet function 1.1-4.4 ng/mL 0.1-40 ng/mL Glycosylated Hemoglobin HbA1c Whole Blood ·One of the indexes for diagnosis and screening of diabetes mellitus ·Objective to investigate the long-term blood glucose control of diabetic patients 4.0%-6.0% 4.0%-14% Bone Metabolism 25-Hydroxy-Vitamin D 25(OH)VD Serum/Plasma/Whole Blood ·Diagnosis and detection of rickets (children), osteomalacia, postmenopausal osteoporosis and nephropathy ≧30 ng/mL 4-60 ng/mL Fertility *Total β subunit human chorionic gonadotropin β-HCG Serum/Plasma/Whole Blood ·For the diagnosis of early pregnancy. ＜5 mIU/L 5-30000 mIU/L *Progesterone PROG Serum/Plasma/Whole Blood ·Track ovulation and placenta function Male: 0.14-2.06 ng/mL Female Follicular Phase: 0.31-1.52 ng/mL Female Luteal Phase: 5.16-18.56 ng/mL Female Menopause:＜0.78 ng/mL 0.30-40.00 ng/mL Thyroid Hormone *Thyroid-stimulating hormone TSH Serum/Plasma/Whole Blood ·Evaluation of therapeutic effect and prognosis of thyroid diseases 0.51-6.27 mIU/L 0.1-100 mIU/L *Triiodothyronine/Thyroxine  & 2-in-1 TT3/TT4 Serum/Plasma/Whole Blood ·Detection in...

The COVID-19 and Influenza A+B Antigen Combo Rapid Test is intended for use by trained clinical laboratory personnel.

The kit is a TaqMan probe real-time fluorescent PCR to qualitatively detect ORF1ab, N genes nucleic acid of 2019-nCoV in throat swab, sputum in patients with suspected pneumonia symptoms and Clustering cases.

For nucleic acid extraction, enrichment, purification and other steps. The processed products are used for clinical in vitro diagnosis use.

The Neutralizing Antibody Test Kit (Colloidal Gold) is used for the rapid, qualitative detection of the Neutralizing Antibody in human whole blood, serum, plasma and fingertip blood in vitro, for an aid identifying individuals with an adaptive immune response to COVID-19

The cassette is used for the qualitative detection of novel coronavirus antigen in human oropharyngeal swabs or nasopharyngeal swabs in vitro.

The cassette is used for the qualitative detection of novel coronavirus antigen in human oropharyngeal swabs or nasopharyngeal swabs in vitro.